SEC Form 4Coverage since May 27, 2026
$FLGT insider trading
Over the last 12 months, Fulgent Genetics insiders reported no purchases and 4 sales totaling $106K across SEC Form 4 filings.
- Bought · 12m
- — 0 events
- Sold · 12m
- $106K 4 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $FLGT · 12Mvia TradingView
Top insiders · 12m
Gao HanlinChief Scientific Officer2× · $47K
Xie JianPresident and COO2× · $60K
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | Xie JianPresident and COO · O | ▼ Sale | 2,146 | $17.89 | $38K | -0.6% | — |
| Jun 2, 2026 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 1,688 | $17.89 | $30K | -0.2% | — |
| May 27, 2026 | Xie JianPresident and COO · O | ▼ Sale | 1,201 | $17.6 | $21K | -0.3% | — |
| May 27, 2026 | Gao HanlinChief Scientific Officer · O | ▼ Sale | 945 | $17.6 | $17K | -0.1% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $FLGT feed.